Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

I B Runnebaum; S Wang-Gohrke; D Vesprini; R Kreienberg; H Lynch; R Moslehi; P Ghadirian; B Weber; A K Godwin; H Risch

doi:10.1097/00008571-200110000-00010

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

Identifier:nobleid.org/w1/20260515/5EE057EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5EE057EB.svg?ark=w1%2F20260515%2F5EE057EB)](https://nobleid.org/work/w1/20260515/5EE057EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

Identifier:nobleid.org/w1/20260515/5EE057EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5EE057EB.svg?ark=w1%2F20260515%2F5EE057EB)](https://nobleid.org/work/w1/20260515/5EE057EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work